BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1723081)

  • 1. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms.
    Kamino H; Tam ST
    J Cutan Pathol; 1991 Dec; 18(6):436-9. PubMed ID: 1723081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma.
    Kligora CJ; Fair KP; Clem MS; Patterson JW
    Mod Pathol; 1999 Dec; 12(12):1143-7. PubMed ID: 10619267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of the blue hue in dermoscopy of melanocytic lesions: a dermoscopic-pathologic study.
    Massi D; De Giorgi V; Carli P; Santucci M
    Am J Dermatopathol; 2001 Oct; 23(5):463-9. PubMed ID: 11801781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound blue nevus: a variant of blue nevus with an additional junctional dendritic component. A clinical, histopathologic, and immunohistochemical study of six cases.
    Kamino H; Tam ST
    Arch Dermatol; 1990 Oct; 126(10):1330-3. PubMed ID: 2221938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of heavily pigmented melanocytic lesions: challenges and diagnostic approach.
    Aung PP; Mutyambizi KK; Danialan R; Ivan D; Prieto VG
    J Clin Pathol; 2015 Dec; 68(12):963-70. PubMed ID: 26602414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined variant of Spitz's nevi. How to differentiate them from malignant melanomas.
    Rogers GS; Advani H; Ackerman AB
    Am J Dermatopathol; 1985; 7 Suppl():61-78. PubMed ID: 3940093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spitz's nevi with halo reaction: a histopathologic study of 17 cases.
    Harvell JD; Meehan SA; LeBoit PE
    J Cutan Pathol; 1997 Nov; 24(10):611-9. PubMed ID: 9449488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical comparison between MiTF and MART-1 with Azure blue counterstaining in the setting of solar lentigo and melanoma in situ.
    Hillesheim PB; Slone S; Kelley D; Malone J; Bahrami S
    J Cutan Pathol; 2011 Jul; 38(7):565-9. PubMed ID: 21362015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epithelioid and hyperpigmented melanocytic tumors. An overview].
    Kutzner H; Schärer L; Requena L
    Pathologe; 2007 Nov; 28(6):411-21. PubMed ID: 17899087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Black lesions of the skin.
    BECKER SW
    Calif Med; 1958 Mar; 88(3):228-33. PubMed ID: 13511215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple immunochemical technique for distinguishing melanocytes and melanophages in paraffin-embedded tissue.
    Fleming MG; Bergfeld WF
    J Cutan Pathol; 1990 Apr; 17(2):77-81. PubMed ID: 1692575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
    Gown AM; Vogel AM; Hoak D; Gough F; McNutt MA
    Am J Pathol; 1986 May; 123(2):195-203. PubMed ID: 3518473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.
    Smolle J; Soyer HP; Juettner FM; Hoedl S; Kerl H
    Pathol Res Pract; 1988 Jun; 183(3):266-70. PubMed ID: 3420029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uncommon variants of malignant melanocytic neoplasms].
    Mentzel T
    Pathologe; 2007 Nov; 28(6):445-52. PubMed ID: 17846776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of vascularity in nodular melanoma and Spitz's nevus.
    Binder M; Steiner A; Mossbacher U; Hunegnaw M; Wolff K; Pehamberger H
    J Cutan Pathol; 1997 May; 24(5):272-7. PubMed ID: 9194579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
    Steuhl KP; Rohrbach JM; Knorr M
    Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HMB 45 positive balloon cells in combined nevi].
    Laaff H; Kühnl-Petzoldt C
    Hautarzt; 1992 Sep; 43(9):566-8. PubMed ID: 1399602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.